565226-34-8

Basic information

• Product Name: (1R,4S,5S,9S,10R,13R,14R,15S,17S,19R,20R)-13-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-4,7,7,10,14,19,20-heptamethyl-2-methylene-17-(2,4,6-trimethyl-phenyl)-6,8,12,16,18-pentaoxa-tricyclo[13.3.1.1^5,9]icosan-11-one
• CAS NO: 565226-34-8
• Molecular Weight: 690.961
• Mol File: 565226-34-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,4S,5S,9S,10R,13R,14R,15S,17S,19R,20R)-13-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-4,7,7,10,14,19,20-heptamethyl-2-methylene-17-(2,4,6-trimethyl-phenyl)-6,8,12,16,18-pentaoxa-tricyclo[13.3.1.1^5,9]icosan-11-one(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,4S,5S,9S,10R,13R,14R,15S,17S,19R,20R)-13-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-4,7,7,10,14,19,20-heptamethyl-2-methylene-17-(2,4,6-trimethyl-phenyl)-6,8,12,16,18-pentaoxa-tricyclo[13.3.1.1^5,9]icosan-11-one(565226-34-8)
• EPA Substance Registry System: (1R,4S,5S,9S,10R,13R,14R,15S,17S,19R,20R)-13-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-4,7,7,10,14,19,20-heptamethyl-2-methylene-17-(2,4,6-trimethyl-phenyl)-6,8,12,16,18-pentaoxa-tricyclo[13.3.1.1^5,9]icosan-11-one(565226-34-8)

Safety Data

• Hazardous Substances Data: 565226-34-8(Hazardous Substances Data)

Upstream product

• 565226-25-7 (R)-2-((4S,5R,6S)-6-{(S)-3-[(2S,4R,5R,6S)-6-((1S,2R,3R,4S)-4-Benzyloxy-2-hydroxy-1,3-dimethyl-pentyl)-5-methyl-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-yl]-1-methyl-but-3-enyl}-2,2,5-trimethyl-[1,3]dioxan-4-yl)-propionic acid 
• 106357-30-6 1-benzyloxy-2(S),4(S)-dimethyl-hex-5-en-3(R)-ol 
• 132409-48-4 (2RS,3SR)-3-O-benzyl-2-methyl-1,3-butanediol 
• 101470-81-9 (2R,3S)-1-Benzyloxymethyloxy-2-methylbutan-3-ol 
• 97718-92-8 (S)-2-[(4R,5S,6S)-6-((S)-2-Benzyloxy-1-methyl-ethyl)-2,2,5-trimethyl-[1,3]dioxan-4-yl]-propan-1-ol 
• 363172-06-9 (2S,3S)-3-Benzyloxy-2-methyl-butyraldehyde 
• 251099-25-9 (2S,3S,4R,5R,6S)-7-(tert-butyldiphenylsilyloxy)-3,5-(isopropylidenedioxy)-2,4,6-trimethyl-heptanol 
• 251099-27-1 (2R,3R,4S,5R,6S)-1-iodo-7-(tert-butyldiphenylsilyloxy)-3,5-(isopropylidenedioxy)-2,4,6-trimethyl-heptane 
• 565226-28-0 (3R,4S,5R,6S)-6-Benzyloxy-3,5-dimethyl-hept-1-en-4-ol 
• 97674-79-8 (2S,3S,4S,5R,6S)-1-Benzyloxy-2,4,6-trimethyl-oct-7-ene-3,5-diol 
• 97689-63-9 (4S,5S,6R)-4-((S)-2-Benzyloxy-1-methyl-ethyl)-2,2,5-trimethyl-6-((S)-1-methyl-allyl)-[1,3]dioxane 
• 565226-29-1 1-[(1S,2R)-1-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-2-methyl-but-3-enyloxymethyl]-4-methoxy-benzene 
• 565226-27-9 4-[(1R,2S)-1-((S)-2-Benzyloxy-1-methyl-ethyl)-2-methyl-but-3-enyloxymethyl]-1,2-dimethoxy-benzene 
• 565226-30-4 (3S,4R,5R,6S,7S,8S)-8-Benzyloxy-6-(4-methoxy-benzyloxy)-3,5,7-trimethyl-non-1-en-4-ol 

Downstream Products

• 565226-35-9 (1S,2R,5S,6R,7R,8R,9R,12S,13S,15S,17R)-5-((1S,2S)-2-Benzyloxy-1-methyl-propyl)-7,9-dihydroxy-2,6,8,12,17-pentamethyl-10-methylene-15-(2,4,6-trimethyl-phenyl)-4,14,16-trioxa-bicyclo[11.3.1]heptadecan-3-one 
• 565226-36-0 C₄₀H₅₈O₈ 
• 565226-37-1 C₄₂H₅₈O₉ 

Relevant articles and documents

The first stereoselective total synthesis of lankanolide. Part 2

The seco-acid derivative designed by conformation calculation and lactonization experiment of model seco-acids was synthesized, and subjected to macrolactonization to afford the lactone derivative. The lankanolide was synthesized via several steps after the lactonization, and the synthetic lankanolide was confirmed to have the same physical data (NMR, mass, IR and αD) as the lankanolide prepared from lankamycin according to the reported method.